Updates, progress and news on biopharmaceutical cooperation between China and Latin America.
Progress on the registration and commercialization strategy for VAMENGOCBC in the Chinese market.
BioBridge expands its international team with five new strategic positions.
The natural supplement developed by CIDEM continues its path toward entry into the Chinese market.
BioBridge representatives presented cooperation opportunities between China and LATAM.
Registration is now open for the annual gathering between biopharmaceutical ecosystems.
Progress continues on the bispecific IL-6 tumor-targeting antagonist.